These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 3358106)
21. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy. Ng F; Mastoroudes H; Paul E; Davies N; Tibballs J; Hochhauser D; Mayer A; Begent R; Meyer T Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):551-6. PubMed ID: 17517500 [TBL] [Abstract][Full Text] [Related]
22. [A safe and simple method of percutaneous transfemoral implantation of a port-catheter access system for hepatic artery chemotherapy infusion]. Kuroiwa T; Honda H; Yoshimitsu K; Irie H; Aibe H; Shinozaki K; Nishie A; Nakayama T; Masuda K Gan To Kagaku Ryoho; 2001 Oct; 28(11):1573-7. PubMed ID: 11707983 [TBL] [Abstract][Full Text] [Related]
23. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma]. Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328 [TBL] [Abstract][Full Text] [Related]
24. A trial with a new peripheral implanted vascular access device. Winters V; Peters B; Coilá S; Jones L Oncol Nurs Forum; 1990; 17(6):891-6. PubMed ID: 2263515 [TBL] [Abstract][Full Text] [Related]
25. Experience with the intravenous totally implanted port in patients with gynecologic malignancies. Nelson BE; Mayer AR; Tseng PC; Schwartz PE Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028 [TBL] [Abstract][Full Text] [Related]
26. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032 [TBL] [Abstract][Full Text] [Related]
27. Peripheral infusion ports for central venous access in patients with gynecologic malignancies. Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645 [TBL] [Abstract][Full Text] [Related]
28. Experience with an implantable venous access system for chemotherapy. Pettengell R; Davies AJ; Harvey VJ N Z Med J; 1991 Jul; 104(915):284-5. PubMed ID: 1852329 [TBL] [Abstract][Full Text] [Related]
29. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients]. Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577 [TBL] [Abstract][Full Text] [Related]
30. Do central venous catheters have advantages over arteriovenous fistulas or grafts? Quarello F; Forneris G; Borca M; Pozzato M J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685 [TBL] [Abstract][Full Text] [Related]
31. [Encapsulated implantable venous access device: two clinical cases]. Guivarch E; Kriegel I; Bonnet L; di Maria S; Estève M Ann Fr Anesth Reanim; 2009 Mar; 28(3):238-41. PubMed ID: 19327941 [TBL] [Abstract][Full Text] [Related]
32. Totally implantable central venous catheters of the port-a-cath type: complications due to its use in the treatment of cancer patients. Granic M; Zdravkovic D; Krstajic S; Kostic S; Simic A; Sarac M; Ivanovic N; Radovanovic D; Dikic S; Kovcin V J BUON; 2014; 19(3):842-6. PubMed ID: 25261677 [TBL] [Abstract][Full Text] [Related]
33. [Complications of the use of implantable reservoirs of central venous access++ in pediatrics: causes and treatment]. Pérez Martínez A; Martínez Ibáñez V; Ezzedine M Cir Pediatr; 1993 Apr; 6(2):59-62. PubMed ID: 8357723 [TBL] [Abstract][Full Text] [Related]
34. Implantable device for venous access. Leclerc YE; Loutfi A Can J Surg; 1987 Mar; 30(2):127-9. PubMed ID: 3828909 [TBL] [Abstract][Full Text] [Related]
35. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients. Koonings PP; Given FT J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727 [TBL] [Abstract][Full Text] [Related]
36. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation]. Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304 [TBL] [Abstract][Full Text] [Related]
37. Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer. Malmström H; Carstensen J; Simonsen E Gynecol Oncol; 1994 Jul; 54(1):27-34. PubMed ID: 8020835 [TBL] [Abstract][Full Text] [Related]
38. [Practical procedure of totally implanted venous access system for outpatient cancer therapy]. Iida S; Egami K; Sasajima K; Hasegawa H; Miyamoto M; Yokoyama T; Suzuki S; Tajiri T Gan To Kagaku Ryoho; 2006 May; 33(5):639-43. PubMed ID: 16685163 [TBL] [Abstract][Full Text] [Related]
39. [Chemotherapy via tunneled central venous catheter left in place between drug courses. Prospective study in 98 ambulatory patients]. Vedrenne JB; Estève M; Pouillart P; Quinet A Bull Cancer; 1985; 72(3):236-9. PubMed ID: 4074908 [TBL] [Abstract][Full Text] [Related]